Search Results - "Boyle, Jordan N"

CUDC-907: An Oral HDAC/PI3K Dual Inhibitor with Strong Preclinical Efficacy in MCL Model by Boyle, Jordan N, Kim, Caroline R, Guo, Hui, Bell, Taylor, Huang, Shengjian, Li, Carrie J, Liu, Yang, Zhang, Hui, Wang, Jack, Zhang, Victoria, Ahmed, Makhdum, Lam, Laura T, Nomie, Krystle, Zhang, Liang, Zeng, Dongfeng, Wang, Michael

“…Introduction Mantle cell lymphoma (MCL) is an aggressive lymphoma with elevated B-cell receptor activity. Ibrutinib (IBN), a Bruton's tyrosine kinase (BTK)…”
Get full text

Pre-Clinical Evaluation of the PI3K-p110β/δ Inhibitor KA2237 in Mantle Cell Lymphoma by Huang, Shengjian, Nastoupil, Loretta J., Guo, Hui, Bell, Taylor, Ahmed, Makhdum, Li, Carrie J, Wang, Jack, Liu, Yang, Zhang, Victoria, Kim, Caroline R, Boyle, Jordan N, Lorence, Elizabeth A, Lam, Laura T, Chen, Zhihong, Zhang, Hui, Shuttleworth, Stephen Joseph, Nomie, Krystle, Wang, Michael, Zhang, Liang

“…Background: Mantle cell lymphoma (MCL) accounts for 6% of all non-Hodgkin lymphoma and is a therapeutic challenge. Phosphoinositide-3 kinase (PI3K) has been…”
Get full text